雪灵芝开发研究  

The Development and Research Summary of Xue Lingzhi

作　　者：曹熙德[1] 

机构地区：[1]中国科学院成都生物研究所,四川成都610041

出　　处：《中国肿瘤》2001年第4期227-229,共3页China Cancer

摘　　要：雪灵芝为石竹科蚤缀属植物 ,最早的药用记载可追溯到公元7世纪 ,随后在藏医典籍中的记载日渐增多。近十年来 ,文献报道了对雪灵芝的种群分布、化学成份、毒理、药理以及应用开发等方面进行的深入研究 ,雪灵芝是藏药中的一支奇葩 ,具有重要的开发利用价值。Xue Lingzhi(Herba Arenariae)belongs to Caryophyllaceae Arenaria.The medical value of Herba Arenariae had been recorded early in the 7th century.Later on,it could be found in more and more classical Tibetan medical books.In recent decade years,some science literatures have reported deep research in Xue Lingzhi,namely its distributive pattern,chemical ingredients,toxicology,pharmacology and development.The result indicates that Xue Lingzhi is a wonderful plant in Tibetan and of great value in development and application.

关 键 词：雪灵芝 毒理学 药理学 化学成份 开发 中药 

分 类 号：R282.71[医药卫生—中药学]